documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
17 rows where agency_id = "FDA", document_type = "Rule" and posted_year = 2004 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: docket_id, title, subtype, posted_date, posted_month, comment_start_date, comment_end_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1998-N-0043-0003 | FDA | External Penile Rigidity Devices;Proposed Classification - Closed FDA-1998-N-0043 | Gastroenterology-Urology Devices; Classification for External Penile Rigidity Devices | Rule | Final Rule | 2004-12-28T05:00:00Z | 2004 | 12 | 2024-09-17T12:34:00Z | 04–28252 | 0 | 0 | 090000648056e637 | ||
| FDA-2003-H-0215-0043 | FDA | Civil Money Penalty, Korangy Radiology Associates, PA dba Baltimore Imaging Centers, Amile A Korangy, MD FDA-2003-H-0215 | HF-3 | Rule | IDF-Initial Decision by Admin Law Judge | 2004-12-17T05:00:00Z | 2004 | 12 | 2008-04-12T00:57:14Z | 0 | 0 | 090000648048c765 | |||
| FDA-2003-H-0215-0042 | FDA | Civil Money Penalty, Korangy Radiology Associates, PA dba Baltimore Imaging Centers, Amile A Korangy, MD FDA-2003-H-0215 | HF-3 | Rule | IDF-Initial Decision by Admin Law Judge | 2004-12-17T05:00:00Z | 2004 | 12 | 2008-04-12T00:57:12Z | 0 | 0 | 090000648048c762 | |||
| FDA-2003-N-0213-0002 | FDA | Orthopedic Devices; Effective Date of the Proposed Requirement for Premarket Approval of the Hip Joint Metal/Polymer or Ceramic/Polymer Semi-constrained Resurfacing Cemented Prosthesis FDA-2003-N-0213 | Orthopedic Devices; Effective Date of the Proposed Requirement for Premarket Approval of the Hip Joint Metal/Polymer or Ceramic/Polymer Semiconstrained Resurfacing Cemented Prosthesis | Rule | NFR-Notice of Final Rule | 2004-10-05T04:00:00Z | 2004 | 10 | 2004-10-01T04:00:00Z | 2008-11-17T08:29:45Z | 0 | 0 | 090000648048c350 | ||
| FDA-1998-N-0051-0010 | FDA | Over the Counter Human Drugs Labeling Requirements FDA-1998-N-0051 | Over-the-Counter Human Drugs; Labeling Requirements; Delay of Implementation Date | Rule | Final Rule | 2004-09-07T04:00:00Z | 2004 | 9 | 2004-09-03T04:00:00Z | 2004-12-03T04:59:59Z | 2016-08-25T01:01:10Z | 0 | 0 | 090000648056e93f | |
| FDA-1998-N-0051-0011 | FDA | Over the Counter Human Drugs Labeling Requirements FDA-1998-N-0051 | Over-the-Counter Human Drugs; Labeling Requirements; Delay of Implementation | Rule | NFR-Notice of Final Rule | 2004-09-07T04:00:00Z | 2004 | 9 | 2004-09-03T04:00:00Z | 2004-12-03T04:59:59Z | 2009-04-22T03:55:30Z | 0 | 0 | 090000648056e940 | |
| FDA-1998-N-0051-0009 | FDA | Over the Counter Human Drugs Labeling Requirements FDA-1998-N-0051 | Over-the-Counter Human Drugs; Labeling Requirements; Delay of Implementation Date | Rule | Final Rule | 2004-09-07T04:00:00Z | 2004 | 9 | 2004-09-03T04:00:00Z | 2004-12-03T04:59:59Z | 2016-08-24T14:36:20Z | 0 | 0 | 090000648056e93e | |
| FDA-2000-N-0072-0002 | FDA | Labeling of Menstrual Tampons: Ranges of Absorbency-Closed FDA-2000-N-0072 | Medical Devices; Labeling for Menstrual Tampons; Ranges of Absorbency, Change From “Junior” to “Light” | Rule | Final Rule | 2004-08-25T04:00:00Z | 2004 | 8 | 2004-08-25T04:00:00Z | 2025-06-13T00:09:34Z | 04–19488 | 0 | 0 | 09000064804b027c | |
| FDA-2002-N-0263-0002 | FDA | Classification of Silicone Sheeting-Closed FDA-2002-N-0263 | General and Plastic Surgery Devices; Classification of Silicone Sheeting | Rule | Final Rule | 2004-08-09T04:00:00Z | 2004 | 8 | 2004-08-09T04:00:00Z | 2025-05-13T15:34:44Z | 04–18074 | 0 | 0 | 090000648049c87a | |
| FDA-2004-P-0158-0002 | FDA | de nova Classification of Factor V Leiden Kit - Closed FDA-2004-P-0158 | Medical Devices; Hematology and Pathology Devices; Classification of the Factor V Leiden DNA Mutation Detection Systems Devices | Rule | Final Rule | 2004-03-24T05:00:00Z | 2004 | 3 | 2004-03-15T05:00:00Z | 2004-03-17T04:59:59Z | 2024-12-04T20:55:57Z | 04–5864 | 0 | 0 | 0900006480470050 |
| FDA-2000-N-0109-0074 | FDA | Enrofloxacin for Poultry: Opportunity for Hearing FDA-2000-N-0109 | Proposal to Withdraw Approval of the New Animal Drug Application for Enrofloxacin for Poultry | Rule | Initial Decision by Admin Law Judge | 2004-03-16T05:00:00Z | 2004 | 3 | 2026-01-10T08:15:58Z | 0 | 0 | 09000064804cbe3d | |||
| FDA-2002-N-0016-0007 | FDA | Bar Code Label Requirements for human drug products FDA-2002-N-0016 | FDA - Notice of Final Rule | Rule | NFR-Notice of Final Rule | 2004-02-26T05:00:00Z | 2004 | 2 | 2004-02-25T05:00:00Z | 2009-02-25T14:10:34Z | 0 | 0 | 09000064804887e3 | ||
| FDA-1995-N-0054-13449 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | FDA - Final Rule (pages 201 - 263) | Rule | NFR-Notice of Final Rule | 2004-02-06T05:00:00Z | 2004 | 2 | 2004-02-06T05:00:00Z | 2009-09-17T17:38:05Z | 0 | 0 | 090000648056b41a | ||
| FDA-1995-N-0054-13448 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | FDA - Final Rule (pages 101 - 200) | Rule | NFR-Notice of Final Rule | 2004-02-06T05:00:00Z | 2004 | 2 | 2004-02-06T05:00:00Z | 2009-09-17T17:40:03Z | 0 | 0 | 090000648056b418 | ||
| FDA-1995-N-0054-13447 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | FDA - Final Rule (pages 1 - 100) | Rule | NFR-Notice of Final Rule | 2004-02-06T05:00:00Z | 2004 | 2 | 2004-02-06T05:00:00Z | 2009-09-17T17:39:03Z | 0 | 0 | 090000648056b417 | ||
| FDA-1997-N-0011-0001 | FDA | Human Cellular and Tissue-Based Products FDA-1997-N-0011 | Notice of Final Rule re Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing | Rule | Final Rule | 2004-01-29T05:00:00Z | 2004 | 1 | 2004-01-23T05:00:00Z | 2004-04-27T03:59:59Z | 2016-01-14T18:15:41Z | 0 | 0 | 09000064805c9acf | |
| FDA-1978-N-0007-0004 | FDA | Skin Protectant Drug Products to O. T. C., Astringent Drug Products FDA-1978-N-0007 | Notice of Correction re Skin Protectant Drug Products for Over-the-Counter Human Use, Astringent Drug Products; Final Monograph, Direct Final Rule; and Confirmation of Effective Date | Rule | Correction | 2004-01-29T05:00:00Z | 2004 | 1 | 2018-05-03T16:12:35Z | 04-1262 | 0 | 0 | 09000064805585a5 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;